Fig. (2).

Ninety-day incidences of ST-segment resolution, the composite of death, ventricular fibrillation (VF) within 48 hours, congestive heart failure (CHF) or shock (primary endpoint), and death in the combined-facilitated PCI (black), abciximab-facilitated PCI (gray) and primary PCI (white) groups from the FINESSE study. Enrollment in the study was stopped at 82% of the originally planned sample size due to slow enrollment and financial overruns. There were no differences between treatment arms for the primary composite end point. PCI = percutaneous coronary intervention; * P=0.01 versus combined-facilitated PCI; ** P=0.003 versus combined facilitated PCI